Dianthus Therapeutics, Inc. /DE/ (DNTH) /
The debt of Dianthus Therapeutics, Inc. /DE/ over the past 10 years
Chart Dianthus Therapeutics, Inc. /DE/: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Dianthus Therapeutics, Inc. /DE/ had liquid cash of $404.3M and total debt of $0: net cash of $404.3M. It had more liquid cash than debt at all 9 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $404.3M* | $0 | $404.3M |
| 2024ended Dec 31, 2024 | $275.24M* | $0 | $275.24M |
| 2023ended Dec 31, 2023 | $173.72M* | $0 | $173.72M |
| 2022ended Dec 31, 2022 | $75.49M* | $0 | $75.49M |
| 2021ended Dec 31, 2021 | $176.93M* | $0 | $176.93M |
| 2020ended Dec 31, 2020 | $148.84M* | $0 | $148.84M |
| 2019ended Dec 31, 2019 | $145.73M* | $0 | $145.73M |
| 2018ended Dec 31, 2018 | $142.57M* | $0 | $142.57M |
| 2017ended Dec 31, 2017 | $51.4M | $0 | $51.4M |
| 2016ended Dec 31, 2016 | — | — | — |
Fiscal years as Dianthus Therapeutics, Inc. /DE/ reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Dianthus Therapeutics, Inc. /DE/
- The revenue of Dianthus Therapeutics, Inc. /DE/
- The profitability of Dianthus Therapeutics, Inc. /DE/
- The cash flow of Dianthus Therapeutics, Inc. /DE/
- All of Dianthus Therapeutics, Inc. /DE/'s financials, charted
Companies of a similar size
- EPREPR PROPERTIES
- PAYPaymentus Holdings, Inc.
- IESCIES Holdings, Inc.
- HRIHERC HOLDINGS INC.
- GNTXGENTEX CORPORATION
Not investment advice. This page shows what Dianthus Therapeutics, Inc. /DE/ filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.